TY - JOUR
T1 - Use of electronic nicotine delivery systems among adolescents
T2 - Status of the evidence and public health recommendations
AU - Kamat, Aarti D.
AU - Van Dyke, Alison L.
N1 - Publisher Copyright:
© SLACK Incorporated.
PY - 2017/2
Y1 - 2017/2
N2 - Although the prevalence of tobacco smoking has been declining in recent years, the use of electronic nicotine delivery systems (ENDS) such as of electronic cigarettes, vaporizers, and hookahs has been steadily rising, especially among adolescents. ENDS are not only advertised to children, but their sale via the Internet has made them easily accessible to youth. In general, children perceive ENDS as safe, or at least safer than smoking traditional combustible tobacco products; however, exposure to nicotine may have deleterious effects on the developing brain. Concern also persists that ENDS may be a “starter” drug that may lead to further tobacco, drug, and/or alcohol use. In contrast to this precautionary stance that is associated with calls for legislative oversight of ENDS marketing and sales, harm reductionists claim that the risks posed by ENDS are minor in comparison with those of combustible tobacco products and that ENDS may be used as a means of nicotine replacement for smoking cessation, despite no concrete evidence to support this assertion. Many medical and health-related organizations have produced position statements concerning ENDS use, including among adolescents. This article summarizes the advantages and disadvantages of using ENDS espoused in these position statements, especially as they relate to use among adolescents.
AB - Although the prevalence of tobacco smoking has been declining in recent years, the use of electronic nicotine delivery systems (ENDS) such as of electronic cigarettes, vaporizers, and hookahs has been steadily rising, especially among adolescents. ENDS are not only advertised to children, but their sale via the Internet has made them easily accessible to youth. In general, children perceive ENDS as safe, or at least safer than smoking traditional combustible tobacco products; however, exposure to nicotine may have deleterious effects on the developing brain. Concern also persists that ENDS may be a “starter” drug that may lead to further tobacco, drug, and/or alcohol use. In contrast to this precautionary stance that is associated with calls for legislative oversight of ENDS marketing and sales, harm reductionists claim that the risks posed by ENDS are minor in comparison with those of combustible tobacco products and that ENDS may be used as a means of nicotine replacement for smoking cessation, despite no concrete evidence to support this assertion. Many medical and health-related organizations have produced position statements concerning ENDS use, including among adolescents. This article summarizes the advantages and disadvantages of using ENDS espoused in these position statements, especially as they relate to use among adolescents.
UR - http://www.scopus.com/inward/record.url?scp=85013378466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85013378466&partnerID=8YFLogxK
U2 - 10.3928/19382359-20170111-01
DO - 10.3928/19382359-20170111-01
M3 - Article
C2 - 28192582
AN - SCOPUS:85013378466
SN - 0090-4481
VL - 46
SP - e69-e77
JO - Pediatric annals
JF - Pediatric annals
IS - 2
ER -